UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$438M |
| 2 |
Lockheed Martin
LMT
|
+$402M |
| 3 |
TAL Education Group
TAL
|
+$294M |
| 4 |
Microsoft
MSFT
|
+$269M |
| 5 |
Wells Fargo
WFC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$384M |
| 2 |
Adobe
ADBE
|
+$372M |
| 3 |
Veeva Systems
VEEV
|
+$342M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$289M |
| 5 |
Global Payments
GPN
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.1% |
| 2 | Consumer Discretionary | 13.57% |
| 3 | Healthcare | 12.46% |
| 4 | Financials | 11.55% |
| 5 | Communication Services | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Univest Financial
UVSP
$1.18B
| $635K | ﹤0.01% |
30,874
| – | – |
|
2152
Myers Industries
MYE
$1.29B
| $634K | ﹤0.01% |
30,526
| – | – |
|
2153
Arcturus Therapeutics
ARCT
$211M
| $633K | ﹤0.01% |
14,600
+300
| +2% | +$20.3K |
|
|
ECHO
2154
DELISTED
Echo Global Logistics, Inc.
ECHO
| $633K | ﹤0.01% |
23,585
| – | – |
|
2155
Vanda Pharmaceuticals
VNDA
$302M
| $629K | ﹤0.01% |
47,850
| – | – |
|
|
SP
2156
DELISTED
SP Plus Corporation
SP
| $629K | ﹤0.01% |
21,804
| – | – |
|
2157
Omeros
OMER
$959M
| $626K | ﹤0.01% |
43,844
| – | – |
|
2158
CVR Energy
CVI
$3.13B
| $625K | ﹤0.01% |
41,959
-10,322
| -20% | -$140K |
|
|
SPTN
2159
DELISTED
SpartanNash
SPTN
| $623K | ﹤0.01% |
35,794
| – | – |
|
|
ATRS
2160
DELISTED
Antares Pharma, Inc.
ATRS
| $623K | ﹤0.01% |
156,152
| – | – |
|
2161
CarParts.com
PRTS
$54.7M
| $622K | ﹤0.01% |
+5,020
| New | +$648K |
|
2162
Camping World
CWH
$653M
| $617K | ﹤0.01% |
23,687
-8,157
| -26% | -$239K |
|
2163
Alector
ALEC
$199M
| $617K | ﹤0.01% |
40,747
| – | – |
|
2164
Ethan Allen Interiors
ETD
$603M
| $614K | ﹤0.01% |
30,380
-6,540
| -18% | -$115K |
|
2165
Banc of California
BANC
$2.97B
| $613K | ﹤0.01% |
41,701
| – | – |
|
2166
Energy Recovery
ERII
$443M
| $613K | ﹤0.01% |
44,931
| – | – |
|
2167
Skywest
SKYW
$4.34B
| $610K | ﹤0.01% |
15,129
-11,772
| -44% | -$430K |
|
|
GTHX
2168
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $610K | ﹤0.01% |
33,890
+8,647
| +34% | +$129K |
|
2169
Collegium Pharmaceutical
COLL
$956M
| $610K | ﹤0.01% |
30,434
+2,822
| +10% | +$55.1K |
|
2170
Tompkins Financial
TMP
$1.42B
| $607K | ﹤0.01% |
8,600
+3,348
| +64% | +$212K |
|
2171
Designer Brands
DBI
$333M
| $603K | ﹤0.01% |
78,838
-21,196
| -21% | -$141K |
|
2172
Lands' End
LE
$403M
| $602K | ﹤0.01% |
27,930
+17,186
| +160% | +$316K |
|
|
AMRS
2173
DELISTED
Amyris Inc.
AMRS
| $601K | ﹤0.01% |
97,270
+22,500
| +30% | +$71.9K |
|
2174
BioXcel Therapeutics
BTAI
$27.8M
| $601K | ﹤0.01% |
813
-100
| -11% | -$77.9K |
|
2175
Customers Bancorp
CUBI
$2.77B
| $599K | ﹤0.01% |
32,960
| – | – |
|
Similar funds
UBS AM's Q4 2020 Portfolio in Review
As of Q4 2020, UBS AM held 2,632 positions worth $213B, up 15% from $186B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM's Q4 2020 filing shows 139 new, 1,393 increased, 625 reduced and 83 closed positions. Its largest new stake was Maravai LifeSciences: 3,763,012 shares worth $106M. The largest sale was Mastercard, an estimated $384M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- UBS AM's largest Q4 2020 buy was Maravai LifeSciences: 3,763,012 shares worth $106M.
- UBS AM added most to Apple in Q4 2020, an estimated $438M increase.
- UBS AM's biggest Q4 2020 reduction was Mastercard, cutting an estimated $384M.
- UBS AM fully exited State Street Technology Select Sector SPDR ETF in Q4 2020, selling an estimated $115M.
- UBS AM's ten largest holdings make up 23% of its $213B portfolio in Q4 2020.
- UBS AM opened 139 new positions and closed 83 in Q4 2020.
- UBS AM's portfolio value rose 15% quarter-over-quarter to $213B.
Based on UBS AM's 13F filing for Q4 2020, filed 17 Feb 2021.